Published in Acta Endocrinol Suppl (Copenh) on January 01, 1978
Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine. J Clin Invest (1980) 1.03
Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone. J Clin Invest (1979) 0.99
Interactions between domperidone and ropinirole, a novel dopamine D2-receptor agonist. Br J Clin Pharmacol (1991) 0.82
Comparison of the vasodilator action of dopamine and dopamine agonists in the renal and coronary beds of the dog. Br J Pharmacol (1982) 0.75
Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol (1998) 3.86
Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science (1995) 3.29
Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100-141). Arzneimittelforschung (1975) 2.72
A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med (1995) 2.65
Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev (1996) 2.56
[2-Br-alpha-ergokryptin: influence on fertility and lactation in the rat]. Experientia (1968) 2.33
An afferent pathway for the selective release of vasopressin in response to carotid occlusion and haemorrhage in the cat. J Physiol (1967) 2.30
X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J Pediatr (1991) 2.17
The right to remain psychotic. CMAJ (1991) 2.01
Retinal haemorrhages in an infant following RetCam screening for retinopathy of prematurity. Eye (Lond) (2004) 1.93
Pharmacology of BS 100-141, a centrally acting antihypertensive drug. Clin Exp Pharmacol Physiol (1975) 1.86
Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function. Proc Natl Acad Sci U S A (1985) 1.86
Impact of prenatal diagnosis on survival and early neurologic morbidity in neonates with the hypoplastic left heart syndrome. Pediatrics (2001) 1.79
Survival after reconstructive surgery for hypoplastic left heart syndrome: A 15-year experience from a single institution. Circulation (2000) 1.78
Association of chromosome 22q11 deletion with isolated anomalies of aortic arch laterality and branching. J Am Coll Cardiol (2001) 1.75
Mitochondrial and nonmitochondrial citrate synthases in Saccharomyces cerevisiae are encoded by distinct homologous genes. Mol Cell Biol (1986) 1.73
Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet (1999) 1.71
Antibodies to histo-blood group substances A and B: agglutination titers, Ig class, and IgG subclasses in healthy persons of different age categories. Transfusion (1991) 1.67
The assay of milk-ejecting activity in the lactating rat. Br J Pharmacol Chemother (1967) 1.63
Chromosomal duplication involving the forkhead transcription factor gene FOXC1 causes iris hypoplasia and glaucoma. Am J Hum Genet (2000) 1.58
Clinical utility and cost-effectiveness of an air suspension bed in the prevention of pressure ulcers. JAMA (1993) 1.57
Does implementing pulse oximetry in a critical care unit result in substantial arterial blood gas savings? Chest (1993) 1.54
DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.50
Metastatic choroidal melanoma to the contralateral orbit 40 years after enucleation. Arch Ophthalmol (1996) 1.49
Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance. Proc Natl Acad Sci U S A (1986) 1.46
Microbial contamination of contact lens cases in the west of Scotland. Br J Ophthalmol (1993) 1.45
Human steroidogenic acute regulatory protein: functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and a pseudogene to chromosome 13. Proc Natl Acad Sci U S A (1995) 1.44
Pharmacological properties of 4(1-methyl-4-piperidylidine)-9,10-dihydro-4H-benzo-[4,5]cyclohepta[1,2]-thiophene hydrogen maleate (pizotifen). Arzneimittelforschung (1977) 1.41
Thrombocytopenia with absent radii (TAR) syndrome: a new increased cellular radiosensitivity syndrome. Clin Oncol (R Coll Radiol) (1995) 1.40
Effects of clonidine and BS 100-141 on the EEG sleep pattern in rats. Eur J Pharmacol (1975) 1.36
Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects? Clin Genet (1987) 1.35
The 22q11.2 deletion: screening, diagnostic workup, and outcome of results; report on 181 patients. Genet Test (1997) 1.33
Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy. Hum Mol Genet (1999) 1.32
Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc Natl Acad Sci U S A (1997) 1.30
The mechanism of the inhibitory action of adrenaline on the mammary gland. Br J Pharmacol Chemother (1967) 1.29
The role of sodium channels in the effects of the cardiotonic compound DPI 201-106 on contractility and membrane potentials in isolated mammalian heart preparations. Eur J Pharmacol (1985) 1.25
Unexpected death after reconstructive surgery for hypoplastic left heart syndrome. Ann Thorac Surg (2001) 1.23
Pediatric chest pain: a prospective study. Pediatrics (1988) 1.22
PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta. J Cardiovasc Pharmacol (1984) 1.19
Role of the steroidogenic acute regulatory protein (StAR) in steroidogenesis. Biochem Pharmacol (1996) 1.14
Blood levels of oxytocin and vasopressin during suckling in the rabbit and the problem of their independent release. J Physiol (1970) 1.13
Characterization of the promoter region of the mouse gene encoding the steroidogenic acute regulatory protein. Mol Endocrinol (1997) 1.12
Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy. Electrophoresis (1999) 1.12
The hypothalamic neurosecretory pathways for the release of oxytocin and vasopressin in the cat. J Physiol (1971) 1.12
Structure, function and pharmacology of voltage-gated sodium channels. Naunyn Schmiedebergs Arch Pharmacol (2000) 1.12
Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs. J Cardiovasc Pharmacol (1984) 1.11
Evidence for inhibition by ICS 205-930 and stimulation by BRL 34915 of K+ conductance in cardiac muscle. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.11
Knowledge of Chlamydia trachomatis genital infection and its consequences in people attending a genitourinary medicine clinic. Sex Transm Infect (1999) 1.08
Substituted phenylacetylguanidines: a new class of antihypertensive agents. Arzneimittelforschung (1975) 1.07
Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann Surg (1996) 1.06
Treatment of a case of lanatoside C intoxication with digoxin-specific F(ab')2 antibody fragments. Am Heart J (1979) 1.00
Pindolol--the pharmacology of a partial agonist. Br J Clin Pharmacol (1982) 1.00
SF-1 (steroidogenic factor-1) and C/EBP beta (CCAAT/enhancer binding protein-beta) cooperate to regulate the murine StAR (steroidogenic acute regulatory) promoter. Mol Endocrinol (1999) 0.99
Diagnosis and therapeutic evaluation of a pediatric case of cardiomyopathy using phosphorus-31 nuclear magnetic resonance spectroscopy. J Am Coll Cardiol (1985) 0.99
Evidence for different receptor sites for the novel cardiotonic S-DPI 201-106, ATX II and veratridine on the cardiac sodium channel. Eur J Pharmacol (1986) 0.98
Heterologous expression of mammalian P450 in COS cells. Methods Enzymol (1991) 0.97
The pyrethroids permethrin and cyhalothrin are potent inhibitors of the mitochondrial complex I. J Pharmacol Exp Ther (1997) 0.96
Role of calmodulin-dependent protein kinase II in the acute stimulation of aldosterone production. J Steroid Biochem Mol Biol (1996) 0.94
Effects of the calcium antagonist PY 108-068 on myocardial tissues in vitro and on reflex tachycardia in vivo. J Cardiovasc Pharmacol (1983) 0.94
Palisaded encapsulated neuroma (solitary circumscribed neuroma of skin) of the eyelid: report of two cases and review of the literature. Br J Ophthalmol (2001) 0.93
Effects of ergot alkaloids on the hypothalamic-pituitary axis. Postgrad Med J (1976) 0.93
Steroidogenic factor-1 influences protein-deoxyribonucleic acid interactions within the cyclic adenosine 3,5-monophosphate-responsive regions of the murine steroidogenic acute regulatory protein gene. Endocrinology (2000) 0.93
Inhibitory effects of clonidine and BS 100-141 on responses to sympathetic nerve stimulation in cats and rabbits. Br J Pharmacol (1975) 0.93
Digitoxin intoxication with severe thrombocytopenia: reversal by digoxin-specific antibodies. Eur J Clin Invest (1983) 0.92
Comparison of codes assessing galactic cosmic radiation exposure of aircraft crew. Radiat Prot Dosimetry (2009) 0.92
Sarcoma of the mitral valve causing coronary arterial occlusion in children. Cardiol Young (2001) 0.91
Effects of the new class III antiarrhythmic drug E-4031 on myocardial contractility and electrophysiological parameters. J Cardiovasc Pharmacol (1991) 0.91
Chest pain in children. Follow-up of patients previously reported. Clin Pediatr (Phila) (1990) 0.90
Effects of pindolol on vascular smooth muscle. Gen Pharmacol (1983) 0.90
Minocycline administered intravenously: pharmacological activity and clinical experience. Curr Ther Res Clin Exp (1974) 0.90
The effects of hydrogen peroxide on steroidogenesis in mouse Leydig tumor cells. Endocrinology (1993) 0.90
Epstein-Barr virus-associated hepatic smooth muscle neoplasm in a cardiac transplant recipient. Transplantation (1996) 0.88
Medium chain triglyceride oil ketogenic diets in the treatment of childhood epilepsy. J Hum Nutr (1978) 0.87
Antiarrhythmic effects of DPI 201-106. Br J Pharmacol (1986) 0.87
Identification of a cardiac sodium channel insensitive to synthetic modulators. J Cardiovasc Pharmacol Ther (2001) 0.86
Posterior axial corneal malformation and uveoretinal angiodysgenesis--a neurocristopathy? Graefes Arch Clin Exp Ophthalmol (1990) 0.86
5-Hydroxytryptamine mediated contractions in isolated preparations of equine ileum and pelvic flexure: pharmacological characterization of a new 5-HT(4) agonist. J Vet Pharmacol Ther (2002) 0.86
Proceedings: Pharmacological studies with LL 21-945, a new beta-adrenoceptor blocking agent with a long duration of action. Br J Pharmacol (1974) 0.86
Steroid production after in vitro transcription, translation, and mitochondrial processing of protein products of complementary deoxyribonucleic acid for steroidogenic acute regulatory protein. Endocrinology (1995) 0.86
Recommendations for protein and amino acid intake in phenylketonuric patients. Eur J Pediatr (1996) 0.85
Solid-phase extraction and optimized separation of doxorubicin, epirubicin and their metabolites using reversed-phase high-performance liquid chromatography. J Pharm Biomed Anal (1993) 0.85
Elements involved in the regulation of the StAR gene. Mol Cell Endocrinol (2001) 0.85
Pharmacology of guanfacine. Br J Clin Pharmacol (1980) 0.85
A comparative study of the cardiovascular reactivity in various hypertensive and in normotensive rats. Arzneimittelforschung (1971) 0.85
Proceedings: Inhibition of effects of accelerator nerve stimulation in cats and rabbits by BS 100-141 and guanabenz. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.85
Point prevalence of cardiac abnormalities in children with systemic lupus erythematosus. J Rheumatol (2001) 0.85
Bilateral sequential lung transplant for ectodermal dysplasia. Ann Thorac Surg (2000) 0.84
Retinal hemorrhages: evidence of abuse or abuse of evidence? Am J Forensic Med Pathol (2001) 0.84
Pharmacological actions of APP 201-533, a novel cardiotonic agent. J Cardiovasc Pharmacol (1985) 0.84
The role of the steroidogenic acute regulatory protein in steroidogenesis. Steroids (1997) 0.84
Longitudinal spin-order-based pulse sequence for lactate editing. Magn Reson Med (1991) 0.84
Detection of a 22q11.2 deletion in cardiac patients suggests a risk for velopharyngeal incompetence. Pediatrics (1997) 0.84
Generating and influencing Torsades de Pointes--like polymorphic ventricular tachycardia in isolated guinea pig hearts. Basic Res Cardiol (1998) 0.84
Extracorporeal membrane oxygenation for patients with refractory ventricular arrhythmias. J Thorac Cardiovasc Surg (1999) 0.83
Steroidogenic factor 1 acts at all levels of the reproductive axis. Steroids (1997) 0.83
Resolution of the enantiomers of oxamniquine by capillary electrophoresis and high-performance liquid chromatography with cyclodextrins and heparin as chiral selectors. J Chromatogr A (1995) 0.83
Pertussis toxin treatment does not inhibit the effects of the potassium channel opener BRL 34915 on rat isolated vascular and cardiac tissues. Naunyn Schmiedebergs Arch Pharmacol (1988) 0.83
Comparison of various cosolvency models for calculating solute solubility in water-cosolvent mixtures. Int J Pharm (1999) 0.82